Long Term Stability Evaluation of Prostacyclin Released from Biomedical Device Through Turbiscan Lab Expert

Therapeutic guidelines indicate prostacyclin as the first line of treatment in inflammation and vascular diseases. Prostacyclins prevent formation of the platelet plug involved in primary hemostasis by inhibiting platelet activation and, combined with thromboxane, are effective vasodilators in vascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Celia, Christian, Locatelli, Marcello, Cilurzo, Felisa, Cosco, Donato, Gentile, Emanuela, Scalise, Daniela, Carafa, Maria, Ventura, Cinzia Anna, Fleury, Mathias, Tisserand, Christelle, Barbacane, Renato C., Fresta, Massimo, Marzio, Luisa Di, Paolino, Donatella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475780/
https://www.ncbi.nlm.nih.gov/pubmed/25381994
http://dx.doi.org/10.2174/1573406410666141110153502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475780/
https://www.ncbi.nlm.nih.gov/pubmed/25381994
http://dx.doi.org/10.2174/1573406410666141110153502

Ejemplares similares